Pathophysiological aspects of the interaction between endogenous natriuretic factors and digoxin-like substances as different functional systems of central nervous system regulation: a systematic review
DOI:
https://doi.org/10.12775/PPS.2025.24.64876Keywords
endogenous natriuretic factors, digitalis-like substances, central nervous system, Na-K-ATPase, circadian rhythms, ion transport, neuromodulationAbstract
Background: Endogenous natriuretic factors (ENFs) and digitalis-like substances (DLS) are key endogenous regulators influencing the central nervous system (CNS) through distinct molecular mechanisms. ENFs, including atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), primarily regulate water-salt balance and vascular tone through guanylate cyclase receptor activation, while DLS, including endogenous ouabain and marinobufagenin, modulate Na-K-ATPase activity, affecting neuronal excitability and intracellular signaling cascades.
Objective: To conduct a comprehensive systematic analysis of ENFs and DLS as functionally distinct CNS regulatory systems, evaluating their molecular mechanisms, clinical significance, and therapeutic potential.
Methods: A systematic search was conducted in PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library databases from 1957 to 2025. Search terms included: "endogenous natriuretic factors", "digitalis-like substances", "central nervous system regulation", "Na-K-ATPase inhibition", "ouabain-like compounds", "marinobufagenin". Study selection followed PRISMA 2020 guidelines with independent screening by two reviewers. Quality assessment used Cochrane RoB 2.0 for RCTs and Newcastle-Ottawa Scale for observational studies.
Results: From 1,247 identified publications, 89 studies met inclusion criteria (n=15,847 participants). ENFs affect the CNS via cGMP-dependent mechanisms, reducing sympathetic activity by 20-35% and modulating neurotransmission through NPR-A, NPR-B, and NPR-C receptors. DLS activate Src-kinase cascades through selective inhibition of Na-K-ATPase α-subunits, influencing circadian rhythms and cognitive functions. In pathological conditions, characteristic imbalances were observed: DLS levels increased 1.5-2.8-fold in essential hypertension and depression, while ENF activity decreased 25-40% in neurodegenerative diseases.
Conclusions: ENFs and DLS function as independent but interconnected regulatory systems with significant therapeutic potential. Understanding their distinct mechanisms opens new avenues for developing personalized treatment strategies for neurological disorders.
References
Adair, C., Haupert, G., Koh, H., Wang, Y., Veille, J., & Buckalew, V. (2009). Erythrocyte sodium/potassium ATPase activity in severe preeclampsia. Journal of Perinatology, 29(4), 280-283. https://doi.org/10.1038/jp.2008.223
Badiuk, N. S., Bilas, V. R., Gozhenko, A. I., Gozhenko, O. A., Hrytsak, M. V., Hrytsan, I. I., Klishch, I. M., Korda, M. M., Popovych, A. I., Popovych, D. V., Popovych, I. L., Zavidnyuk, Y. V., Żukow, X., & Zukow, W. (2022). Mineral waters, metabolism, neuro-endocrine-immune complex (I. L. Popovych, A. I. Gozhenko, M. M. Korda, I. M. Klishch, D. V. Popovych, & W. Zukow, Eds.). https://doi.org/10.5281/zenodo.6604298
Bagrov, A. Y., Roukoyatkina, N. I., Pinaev, A. G., Dmitrieva, R. I., & Fedorova, O. V. (1995). Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta. European Journal of Pharmacology, 274(1-3), 151-158. https://doi.org/10.1016/0014-2999(94)00735-p
Bagrov, A. Y., Shapiro, J. I., & Fedorova, O. V. (2009). Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacological Reviews, 61(1), 9-38. https://doi.org/10.1124/pr.108.000711
Bao, J., Hu, P., She, Q., Zhang, D., Mo, J., & Li, A. (2022). A bibliometric and visualized analysis of uremic cardiomyopathy from 1990 to 2021. Frontiers in Cardiovascular Medicine, 9, 908040. https://doi.org/10.3389/fcvm.2022.908040
Blaustein, M. P., Zhang, J., Chen, L., Song, H., Raina, H., Kinsey, S. P., Izuka, M., Iwamoto, T., Kotlikoff, M. I., & Hamlyn, J. M. (2009). The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension, 53(2), 291-298. https://doi.org/10.1161/HYPERTENSIONAHA.108.119974
Bressman, M., Repplinger, D., Slater, W., & Patt, M. (2016). Electrophysiologic similarities of overdose between digoxin and bufadienolides found in a Chinese aphrodisiac. Journal of Arrhythmia, 33(1), 76-78. https://doi.org/10.1016/j.joa.2016.05.004
Burtenshaw, D., & Cahill, P. A. (2020). Natriuretic peptides and the regulation of retinal neovascularization. Arteriosclerosis, Thrombosis, and Vascular Biology, 40(1), 7-10. https://doi.org/10.1161/ATVBAHA.119.313566
Cannone, V., Boerrigter, G., Cataliotti, A., Costello-Boerrigter, L. C., Olson, T. M., McKie, P. M., Heublein, D. M., Lahr, B. D., Bailey, K. R., Averna, M., Redfield, M. M., Rodeheffer, R. J., & Burnett, J. C., Jr. (2011). A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community. Journal of the American College of Cardiology, 58(6), 629-636. https://doi.org/10.1016/j.jacc.2011.05.011
Chen, J., Chien, E., & Wang, P. (2002). Progesterone attenuates the inhibitory effects of cardiotonic digitalis on pregnenolone production in rat luteal cells. Journal of Cellular Biochemistry, 86(1), 107-117. https://doi.org/10.1002/jcb.10154
Clerico, A., Giannoni, A., Vittorini, S., & Passino, C. (2011). Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. American Journal of Physiology-Heart and Circulatory Physiology, 301(1), H12-H20. https://doi.org/10.1152/ajpheart.00226.2011
Conlin, P., Moore, T., Williams, G., & Nk, H. (1999). Altered sodium perception in essential hypertensive patients following rapid volume expansion. Journal of Human Hypertension, 13(10), 701-706. https://doi.org/10.1038/sj.jhh.1000852
Daniels, L. B., & Maisel, A. S. (2007). Natriuretic peptides. Journal of the American College of Cardiology, 50(25), 2357-2368. https://doi.org/10.1016/j.jacc.2007.09.021
de Bold, A. J., Borenstein, H. B., Veress, A. T., & Sonnenberg, H. (1981). A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sciences, 28(1), 89-94. https://doi.org/10.1016/0024-3205(81)90370-2
Dorey, T. W., Mackasey, M., Jansen, H. J., McRae, M. D., Bohne, L. J., Liu, Y., Belke, D. D., Atkinson, L., & Rose, R. A. (2022). Natriuretic peptide receptor B maintains heart rate and sinoatrial node function via cyclic GMP-mediated signaling. Cardiovascular Research, 118(8), 1917-1931. https://doi.org/10.1093/cvr/cvab245
Dostanic, I., Schultz, J. E. J., Lorenz, J. N., & Lingrel, J. B. (2004). The alpha 1 isoform of Na,K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heart. Journal of Biological Chemistry, 279(52), 54053-54061. https://doi.org/10.1074/jbc.M410737200
Fedorova, O. V., Anderson, D. E., & Bagrov, A. Y. (1998). Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats. American Journal of Hypertension, 11(7), 796-802. https://doi.org/10.1016/s0895-7061(98)00042-9
Fedorova, O. V., Doris, P. A., & Bagrov, A. Y. (1998). Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clinical and Experimental Hypertension, 20(5-6), 581-591. https://doi.org/10.3109/10641969809053236
Fedorova, O. V., Kolodkin, N. I., Agalakova, N. I., Lakatta, E. G., & Bagrov, A. Y. (2001). Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension, 37(2 Pt 2), 462-466. https://doi.org/10.1161/01.hyp.37.2.462
Fedorova, O. V., Shapiro, J. I., & Bagrov, A. Y. (2010). Endogenous cardiotonic steroids and salt-sensitive hypertension. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1802(12), 1230-1236. https://doi.org/10.1016/j.bbadis.2010.03.011
Fedorova, O. V., Simbirtsev, A. S., Kolodkin, N. I., Kotov, A. Y., Agalakova, N. I., Kashkin, V. A., Tapilskaya, N. I., Bzhelyansky, A., Reznik, V. A., Frolova, E. V., Nikitina, E. R., Budny, G. V., Longo, D. L., Lakatta, E. G., & Bagrov, A. Y. (2008). Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension. Journal of Hypertension, 26(12), 2414-2425. https://doi.org/10.1097/HJH.0b013e328312c86a
Ferrari, P., Torielli, L., Ferrandi, M., Padoani, G., Duzzi, L., Florio, M., Conti, F., Melloni, P., Vesci, L., Corsico, N., & Bianchi, G. (1998). PST2238: A new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. Journal of Pharmacology and Experimental Therapeutics, 285(1), 83-94. https://doi.org/10.1016/S0022-3565(24)37374-4
Filipets, N. D. (1997a). The role of the natriuretic hormone in the action of nifedipine and verapamil on the kidneys. Eksperimentalnaya i Klinicheskaya Farmakologiya, 60(1), 40-41.
Filipets, N. D. (1997b). Порівняльний вплив деяких блокаторів кальцієвих каналів на показники волюморегуляції та функції нирок [Comparative influence of some calcium channel blockers on volume regulation indices and kidney function] [Doctoral dissertation, Institute of Pharmacology and Toxicology, Academy of Medical Sciences of Ukraine].
Filipets, N. D., Gerush, I. V., Gerush, O. V., Filipets, O. O., Vlasyk, L. I., Kmet, O. G., & Gozhenko, A. I. (2025). Founders of Bukovina medical scientific schools: Professor Yuriy Ivanovych Ivanov. Clinical and Experimental Pathology, 24(2), 106-110. https://doi.org/10.24061/1727-4338
Filipets, N. D., Gerush, O. V., Filipets, O. O., Kmet, O. G., Gabunia, L., & Hozhenko, A. I. (2023). Natriuretic factor as a mechanism and pharmacological target of the regulation of water and electrolyte metabolism in the research works of the Bukovinian scientific school. Actual Problems of Transport Medicine, 1-2, 45-52.
Filipets, N. D., Gozhenko, A. I., Ivanov, D. D., Filipets, O. O., & Gabunia, L. (2022). Regulatory mechanisms for maintaining homeostasis of sodium ions. KIDNEYS, 11(3), 175-180. https://doi.org/10.22141/2307-1257.11.3.2022.378
Francis, S. H., Busch, J. L., Corbin, J. D., & Sibley, D. (2010). cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacological Reviews, 62(3), 525-563. https://doi.org/10.1124/pr.110.002907
Gallo, G., Bianchi, F., Cotugno, M., Volpe, M., & Rubattu, S. (2020). Natriuretic peptides, cognitive impairment and dementia: An intriguing pathogenic link with implications in hypertension. Journal of Clinical Medicine, 9(7), 2265. https://doi.org/10.3390/jcm9072265
Gallo, G., Rubattu, S., Autore, C., & Volpe, M. (2023). Natriuretic peptides: It is time for guided therapeutic strategies based on their molecular mechanisms. International Journal of Molecular Sciences, 24(6), 5131. https://doi.org/10.3390/ijms24065131
Gantzel, R. H., Kjær, M. B., Jepsen, P., Aagaard, N. K., Watson, H., Gluud, L. L., Vilstrup, H., & Grønbæk, H. (2022). Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis. World Journal of Hepatology, 14(4), 827-845. https://doi.org/10.4254/wjh.v14.i4.827
Goetze, J. P., Bruneau, B. G., Ramos, H. R., Ogawa, T., de Bold, M. K., & de Bold, A. J. (2020). Cardiac natriuretic peptides. Nature Reviews Cardiology, 17(11), 698-717. https://doi.org/10.1038/s41569-020-0381-0
Gonick, H. C. (2014). Evidence for a 12 kDa "carrier protein" for natriuretic hormone. Frontiers in Endocrinology, 5, 196. https://doi.org/10.3389/fendo.2014.00196
Gozhenko, A., Smagliy, V., Korda, I., Badiuk, N., Zukow, W., Kovbasnyuk, M., & Popovych, I. (2020). Relationships between parameters of uric acid exchange and immunity as well as microbiota in patients with neuroendocrine-immune complex dysfunction. Journal of Education, Health and Sport, 10(1), 165-175. https://doi.org/10.12775/JEHS.2020.10.01.019
Gozhenko, A. I. (1976a). O mechanizme mochegonnogo dejstvija nekotoryh gormonal'nyh i gumoral'nyh faktorov [On the mechanism of diuretic action of some hormonal and humoral factors]. W Farmakologija - zdravoohraneniju: Tez. dokl. IV Vsesojuzn. s"ezda farmakologov (ss. 67-68). Leningrad.
Gozhenko, A. I. (1976b). Vodno-solevoj obmen i dejatel'nost' pochek pri glomerulonefrite [Water-salt metabolism and kidney activity in glomerulonephritis]. W Tez. dokl. II s"ezda patofiziologov (T. 2, ss. 76-77). Tashkent.
Gozhenko, A. I. (1983). Vydelenie iz plazmy krovi frakcij, soderzhaschih natrijureticheskij gormon i ih testirovanie v opytah [Isolation of fractions containing natriuretic hormone from blood plasma and their testing in experiments]. Problemy endokrinologii, 29(3), 1123-1126.
Gozhenko, A. I. (1984). Osmoreguliruschaja funkcija pochek pri hronicheskom nefrite [Osmoregulatory function of kidneys in chronic nephritis]. Patofiziologija i eksperimental'naja terapija, 4, 56-60.
Gozhenko, A. I. (1985). Vlijanie progesterona na ionoreguliruschuju funkciju pochek [Effect of progesterone on ion-regulating function of kidneys]. Problemy endokrinologii, 31, 2134-2138.
Gozhenko, A. I. (1989). Gormonal'naja reguljacija vodno-solevogo obmena v norme i pri patologii [Hormonal regulation of water-salt metabolism in norm and pathology]. Uspehi sovremennoj biologii, 107(2), 234-248.
Gozhenko, A. I. (2007). Cikl oksida azota i NO-sintaznye sistemy v miokarde [Nitric oxide cycle and NO-synthase systems in myocardium]. LERADRUK.
Gozhenko, A. I. (2015). Osnovy postroenija teorii bolezni: monografija [Fundamentals of disease theory construction: monograph]. Feniks.
Gozhenko, A. I., & Bagrij, M. M. (1988). Vlijanie endogennyh digitalisopodobnyh soedinenij na aktivnost' Na-K-ATFazy eritrocitov [Effect of endogenous digitalis-like compounds on Na-K-ATPase activity of erythrocytes]. Ukrainskij biohimicheskij zhurnal, 60(4), 56-61.
Gozhenko, A. I., Bagrij, M. M., & Docenko, E. A. (1987). Endogennye ingibitory Na-K-ATFazy pri gipertonicheskoj bolezni [Endogenous Na-K-ATPase inhibitors in hypertensive disease]. Kardiologija, 27(8), 35-39.
Gozhenko, A. I., Bagrij, M. M., & Ivanov, D. D. (1985). Rol' pochek v reguljacii arterial'nogo davlenija [Role of kidneys in arterial pressure regulation]. Vrachebnoe delo, 8, 23-27.
Gozhenko, A. I., Biryukov, V., Gozhenko, O., & Zukow, W. (2018). Health as a space-time continuum. Journal of Education, Health and Sport, 8(11), 763-777. https://doi.org/10.5281/zenodo.2657000
Gozhenko, A. I., Filipets, N. D., Filipets, O. O., & Gozhenko, O. A. (2018). Nephroprotective properties of ATP-sensitive potassium channels agonist flocalin. Fiziolohichnyi Zhurnal, 64(2), 23-29.
Gozhenko, A. I., Filipets, N. D., Filipets, O. O., Shuhtin, V. V., Dzetsiukh, T. I., & Gozhenko, O. A. (2016). Вплив активізації АТР-залежних калієвих каналів флокаліном на стан протеолізу і фібринолізу в умовах експериментального хронічного пошкодження нирок [The effect of ATP-dependent potassium channels activation by flocalin on the state of proteolysis and fibrinolysis under conditions of experimental chronic kidney damage]. Likarska Sprava, 7-8, 133-137.
Gozhenko, A. I., Gubsky, Y. I., Filipets, N. D., Filipets, O. O., & Gozhenko, O. A. (2017). The experimental investigation of fibrinolytic system under the influence of flocalin in conditions of acute hypoxic kidney injury. The Ukrainian Biochemical Journal, 89(6), 49-55. https://doi.org/10.15407/ubj89.04.049
Gozhenko, A. I., Gurkalova, I. P., Zukow, W., & Kwasnik, Z. (2018). Pathogenic role of endogenous intoxication in development of broncho-obstructive pathology in patients, living in environmentally "aggressive" region. Journal of Education, Health and Sport, 8(11), 229-243.
Gozhenko, A. I., Hrytsak, Y. L., Barylyak, L. G., Kovbasnyuk, M. M., Tkachuk, S. P., Korolyshyn, T. A., Kul'chyns'kyi, A. B., Zukow, W., & Popovych, I. L. (2016). Features of immunity by various constellations of principal adaptation hormones and autonomous regulation in practically healthy people. Journal of Education, Health and Sport, 6(10), 215-235. https://apcz.umk.pl/JEHS/article/view/3936
Gozhenko, A. I., & Koloskova, R. P. (1986). Narushenija elektrolitnogo obmena pri hronicheskoj pochechnoj nedostatochnosti [Electrolyte metabolism disorders in chronic renal failure]. Terapevticheskij arhiv, 58(4), 78-82.
Gozhenko, A. I., Kokoshchuk, G. I., Lobach, A. D., & Koloskova, R. P. (1976). K voprosu o vzaimodejstvii pochek i serdechno-sosudistoj sistemy [On the interaction between kidneys and cardiovascular system]. W Funkcional'noe sostojanie pochek pri ekstremal'nyh uslovijah: Mater. Vsesojuzn. simpoziuma (ss. 23-24). Leningrad.
Gozhenko, A. I., Kravchuk, A. V., Nikitenko, O. P., Moskalenko, O. M., & Sirman, V. M. (2015). Funkcional'nyj nyrkovyj rezerv: monografija [Functional renal reserve: monograph]. Feniks.
Gozhenko, A. I., Sirman, V. M., Filipets, N. D., & Filipets, O. O. (2016). Functional state of kidneys after injection of fetal liver cells to the rats with water and salt drinking regime under the conditions of acute sublimate nephropathy. Medychna ta Klinichna Khimiya, 18(2), 61-65. https://doi.org/10.11603/mcch.2410-681X.2016.v0.i1.6185
Gozhenko, A. I., Sydoruk, N. O., Babelyuk, V. Y., Dubkova, G. I., Flyunt, V. R., Hubyts'kyi, V. Y., Zukow, W., & Popovych, I. L. (2016). Modulating effects of bioactive water Naftussya from layers Truskavets' and Pomyarky on some metabolic and biophysic parameters at humans with dysfunction of neuro-endocrine-immune complex. Journal of Education, Health and Sport, 6(12), 826-842. https://apcz.umk.pl/JEHS/article/view/4162
Gozhenko, A. I., Zukow, W., Polovynko, I. S., Zajats, L. M., Yanchij, R. I., Portnichenko, V. I., & Popovych, I. L. (2019). Individual immune responses to chronic stress and their neuro-endocrine accompaniment. RSW. UMK. https://doi.org/10.5281/zenodo.3470144
Gozhenko, O. A. (2013). Відновлювальне лікування хворих на гіпертонічну хворобу з дисциркуляторною енцефалопатією [Restorative treatment of patients with hypertensive disease with dyscirculatory encephalopathy]. Klinichna ta Eksperymentalna Patologiya, 12(2), 58-61.
Gozhenko, O. A. (2018). Balneological clusters of Ukraine: scientific substantiation, treatment and resort development strategies. Boletín de la Sociedad Española de Hidrología Médica, 33(2), 289-290. https://doi.org/10.23853/bsehm.2018.0574
Gozhenko, O. A., Gozhenko, A. I., Gubsky, Y. I., Filipets, N. D., & Filipets, O. O. (2017). The experimental investigation of fibrinolytic system under the influence of flocalin in conditions of acute hypoxic kidney injury. Ukrainian Biochemical Journal, 89(6), 49-55. https://doi.org/10.15407/ubj89.04.049
Gozhenko, O. A., Gozhenko, A. I., Kuznetsova, H. S., Kuznetsova, K. S., Byts, T. M., & Shevchenko, N. O. (2018). Circulating in the blood desquamated endotheliocytes at the diabetic nephropathy. Fiziolohichnyi Zhurnal, 64(2), 34-39. https://doi.org/10.15407/fz64.02.034
Gozhenko, O. A., Gozhenko, A. I., Zukow, W., & Popovych, I. L. (2018). Health as a space-time continuum. Journal of Education, Health and Sport, 8(11), 763-777. https://doi.org/10.5281/zenodo.2657000
Gozhenko, O. A., Lukyanchenko, O. I., Mel'nyk, O. I., Zukow, W., & Popovych, I. L. (2019). Features of the immune profile and microbiota in persons whose immune status is susceptible or resistant to chronic stress. Journal of Education, Health and Sport, 9(3), 601-611.
Gozhenko, O. A., Nikipelova, O. M., & Horbach, L. P. (2012). Медико-біологічна оцінка якості та цінності суміші мінеральних вод свердловин № 5-РГД та № 61-РГД (у співвідношенні 1:5 відповідно) міста Трускавець Львівської області [Medical and biological assessment of the quality and value of the mixture of mineral waters from wells No. 5-RGD and No. 61-RGD (in a ratio of 1:5 respectively) of the city of Truskavets, Lviv region]. Medychna Reabilitatsiya, Kurortologiya, Fizioterapiya, 4, 58.
Gozhenko, O. A., & Volyanska, V. S. (2012). Вплив курсового бальнеолікування із застосуванням хлоридних натрієвих ванн на динаміку клініко-функціональних та гомеостатичних показників у хворих на гіпертонічну хворобу [The influence of course balneotherapy with the use of chloride sodium baths on the dynamics of clinical-functional and homeostatic indicators in patients with hypertensive disease]. Medychna Reabilitatsiya, Kurortologiya, Fizioterapiya, 1, 9-12.
Gozhenko, O. A., Zavidnyuk, Y. V., Korda, M. M., Mysula, I. R., Klishch, I. M., Zukow, W., & Popovych, I. L. (2018). Features of neuro-endocrine and immune reactions to various water-salt loads in female rats. Journal of Education, Health and Sport, 8(9), 11-31.
Haas, M., Askari, A., & Xie, Z. (2000). Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. Journal of Biological Chemistry, 275(36), 27832-27837. https://doi.org/10.1074/jbc.M002951200
Hamlyn, J. M. (2014). Natriuretic hormones, endogenous ouabain, and related sodium transport inhibitors. Frontiers in Endocrinology, 5, 199. https://doi.org/10.3389/fendo.2014.00199
Hamlyn, J. M., Blaustein, M. P., Bova, S., DuCharme, D. W., Harris, D. W., Mandel, F., Mathews, W. R., & Ludens, J. H. (1991). Identification and characterization of a ouabain-like compound from human plasma. Proceedings of the National Academy of Sciences, 88(14), 6259-6263. https://doi.org/10.1073/pnas.88.14.6259
Ivanov, D. D. (2006). Хроническая болезнь почек и хроническая почечная недостаточность у детей [Chronic kidney disease and chronic renal failure in children]. Nefrologiya, 10(3), 123-126.
Ivanov, D. D. (2007). Хроническая болезнь почек и кардиоваскулярные риски: поиск решений [Chronic kidney disease and cardiovascular risks: searching for solutions]. Zdorov'ya Ukrainy, 16-17.
Ivanov, D. D. (2008). Микроальбуминурия: взгляд нефролога [Microalbuminuria: a nephrologist's view]. Zdorovye Ukrainy, 21(1), 18-19.
Ivanov, D. D. (2010). Лекции по нефрологии [Lectures on nephrology]. Izdatel Zaslavskii A. Yu.
Ivanov, D. D. (2012). Острое повреждение почек [Acute kidney injury]. Meditsina Neotlozhnykh Sostoyanii, 16-19.
Ivanov, D. D., Abramov-Sommariva, D., Moritz, K., Eskötter, H., Kostynenko, T., & Romanenko, V. (2015). An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections. Clinical Phytoscience, 1(1), 1-8. https://doi.org/10.1186/s40816-015-0012-3
Ivanov, D. D., & Korzh, O. M. (2006). Нефрологія в практиці сімейного лікаря [Nephrology in family medicine practice]. Vydavets Zaslavskyi O. Yu.
Ivanov, D. D., & Korzh, O. M. (2012). Нефрологія в практиці сімейного лікаря: Навчально-методичний посібник. 2-ге вид., переробл. [Nephrology in family medicine practice: Educational-methodical manual. 2nd ed., revised]. Vydavets Zaslavskyi O. Yu.
Izumi, T., Saito, A., Ida, T., Ukena, K., & Tsutsui, K. (2024). Paracrine and endocrine pathways of natriuretic peptides assessed by ligand-receptor mapping in the Japanese eel brain. Cell and Tissue Research, 396, 197-212. https://doi.org/10.1007/s00441-024-03873-y
Jiang, W., Jiang, H., Pan, C., Cai, D., Qi, Y., Pang, Y., Tang, C., Wu, X., & Wang, J. (2004). Relationship between the contents of adrenomedullin and distributions of neutral endopeptidase in blood and tissues of spontaneously hypertensive rats. Hypertension Research, 27(2), 109-117. https://doi.org/10.1291/hypres.27.109
Kalra, P. R., Clague, J. R., Bolger, A. P., Anker, S. D., Poole-Wilson, P. A., Struthers, A. D., & Coats, A. J. (2003). Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation, 107(4), 571-573. https://doi.org/10.1161/01.cir.0000047280.15244.eb
Kangawa, K., & Matsuo, H. (1984). Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochemical and Biophysical Research Communications, 118(1), 131-139. https://doi.org/10.1016/0006-291X(84)91077-5
Kashkin, V. A., Zvartau, E. E., Fedorova, O. V., Bagrov, Y. Y., Lakatta, E. G., & Bagrov, A. Y. (2008). Endogenous bufadienolide mediates pressor response to ethanol withdrawal in rats. European Neuropsychopharmacology, 18(1), 74-77. https://doi.org/10.1016/j.euroneuro.2007.05.006
Ke, Y., Zhaofang, L., Wang, D., & Wang, H. (2004). Effects of antidigoxin antiserum on endoxin levels, apoptosis and the expression of bax and bcl‐2 protein in ischaemia–reperfusion myocardium. Clinical and Experimental Pharmacology and Physiology, 31(10), 691-695. https://doi.org/10.1111/j.1440-1681.2004.04070.x
Khalaf, F. K., Dube, P., Mohamed, A., Tian, J., Malhotra, D., Haller, S. T., & Kennedy, D. J. (2018). Cardiotonic steroids and the sodium trade balance: New insights into trade-off mechanisms mediated by the Na+/K+-ATPase. International Journal of Molecular Sciences, 19(9), 2576. https://doi.org/10.3390/ijms19092576
Kolmakova, E. V., Haller, S. T., Kennedy, D. J., Isachkina, A. N., Budny, G. V., Frolova, E. V., Piecha, G., Nikitina, E. R., Malhotra, D., Fedorova, O. V., & Bagrov, A. Y. (2011). Endogenous cardiotonic steroids in chronic renal failure. Nephrology Dialysis Transplantation, 26(9), 2912-2919. https://doi.org/10.1093/ndt/gfq772
Kozjavkina, O. V., Kozjavkina, N. V., Gozhenko, O. A., Gozhenko, A. I., Baryljak, L. G., Popovych, I. L., & Povjetkina, T. M. (2015). Bal'neochynnyky kurortu Truskavec' i nejroendokrynno-imunnyj kompleks [Balneofactors of Truskavets resort and neuroendocrine-immune complex]. UNESCO-SOCIO.
Krylatov, A. V., Tsibulnikov, S. Y., Mukhomedzyanov, A. V., Boshchenko, A. A., Jaggi, A. S., Singh, N., & Maslov, L. N. (2021). The role of natriuretic peptides in the regulation of cardiac tolerance to ischemia/reperfusion and postinfarction heart remodeling. Journal of Cardiovascular Pharmacology and Therapeutics, 26(1), 18-37. https://doi.org/10.1177/1074248420952243
Kuhn, M. (2016). Molecular physiology of membrane guanylyl cyclase receptors. Physiological Reviews, 96(2), 751-804. https://doi.org/10.1152/physrev.00022.2015
Kul'chyns'kyi, A. B., Kovbasnyuk, M. M., Korolyshyn, T. A., Kyjenko, V. M., Zukow, W., & Popovych, I. L. (2016). Neuroimmune relationships at patients with chronic pyelonephrite and cholecystite. Communication 2. Correlations between parameters EEG, HRV and phagocytosis. Journal of Education, Health and Sport, 6(10), 377-401. https://doi.org/10.5281/zenodo.163221
Kul'chyns'kyi, A. B., Kyjenko, V. M., Zukow, W., & Popovych, I. L. (2017). Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count. Open Medicine, 12(1), 201-213. https://doi.org/10.1515/med-2017-0030
Kuznetsova, T., Manunta, P., Casamassima, N., Messaggio, E., Jin, Y., Thijs, L., Richart, T., Fagard, R., Hamlyn, J. M., & Staessen, J. A. (2009). Left ventricular geometry and endogenous ouabain in a Flemish population. Journal of Hypertension, 27(9), 1884-1891. https://doi.org/10.1097/hjh.0b013e32832e49a8
Levin, E. R., Gardner, D. G., & Samson, W. K. (1998). Natriuretic peptides. New England Journal of Medicine, 339(5), 321-328. https://doi.org/10.1056/NEJM199807303390507
Lingrel, J. B. (2010). The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase. Annual Review of Physiology, 72, 395-412. https://doi.org/10.1146/annurev-physiol-021909-135725
Lofaro, D., Jager, K. J., Abu-Hanna, A., Groothoff, J. W., Arikoski, P., Hoecker, B., Roussinov, D., Stefanidis, C. J., Bjerre, A., Zurowska, A., Bonthuis, M., Harambat, J., Holmberg, C., Ivanov, D., Jankauskiene, A., Paglialonga, F., Palsson, R., Topaloglu, R., Van Hoeck, K., ... Schaefer, F. (2016). Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry. Nephrology Dialysis Transplantation, 31(2), 317-324. https://doi.org/10.1093/ndt/gfv322
Mankovsky, B. N., & Ivanov, D. D. (2009). Распространенность поражения почек у больных сахарным диабетом 2 типа, по данным эпидемиологического исследования СКИФ [Prevalence of kidney disease in patients with type 2 diabetes mellitus according to the epidemiological study SCIF]. Serdtse i Sosudy, 045-049.
Mankovsky, B. N., & Ivanov, D. D. (2010). Влияние антигипертензивной терапии на функцию почек у больных сахарным диабетом 2-го типа: результаты проспективного исследования «СКИФ-2» [The effect of antihypertensive therapy on kidney function in patients with type 2 diabetes mellitus: results of the prospective study "SCIF-2"]. Liky Ukrainy, 144(8), 28-32.
Manunta, P., Hamilton, B. P., & Hamlyn, J. M. (2006). Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 290(3), R553-R559. https://doi.org/10.1152/ajpregu.00648.2005
Marck, P. V., & Pierre, S. V. (2018). Na/K-ATPase signaling and cardiac pre/postconditioning with cardiotonic steroids. International Journal of Molecular Sciences, 19(8), 2336. https://doi.org/10.3390/ijms19082336
Mark, P. D., & Goetze, J. P. (2021). C-Type natriuretic peptide and its receptors. In S. Offermanns & W. Rosenthal (Eds.), Encyclopedia of molecular pharmacology. Springer. https://doi.org/10.1007/978-3-030-57401-7_6235
McMurray, J. J., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., Zile, M. R., & PARADIGM-HF Investigators. (2014). Angiotensin–neprilysin inhibition versus enalapril in heart failure. New England Journal of Medicine, 371(11), 993-1004. https://doi.org/10.1056/NEJMoa1409077
Mekahli, D., van Stralen, K. J., Bonthuis, M., Jager, K. J., Balat, A., Benetti, E., Bjerre, A., Collard, L., Holmberg, C., Ivanov, D., Jankauskiene, A., Koster-Kamphuis, L., Paglialonga, F., Palsson, R., Roussinov, D., Stefanidis, C. J., Topaloglu, R., Van Hoeck, K., Vondrak, K., ... Schaefer, F. (2016). Kidney versus combined kidney and liver transplantation in young people with autosomal recessive polycystic kidney disease: data from the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant Association registry. American Journal of Kidney Diseases, 68(5), 782-788. https://doi.org/10.1053/j.ajkd.2016.06.019
Mirczuk, S. M., Lessey, A. J., Catterick, A. R., Perrett, R. M., Loughney, A. D., Baxter, G. F., Cooke, B. A., Schulster, D., & Fowkes, R. C. (2019). Regulation and function of C-type natriuretic peptide (CNP) in gonadotrope-derived cell lines. Cells, 8(9), 1086. https://doi.org/10.3390/cells8091086
Nakagawa, Y., & Nishikimi, T. (2022). CNP, the third natriuretic peptide: Its biology and significance to the cardiovascular system. Biology, 11(7), 986. https://doi.org/10.3390/biology11070986
Nakamura, S., Naruse, M., Naruse, K., Kawana, M., Nishikawa, T., Hosoda, S., Tanaka, I., Yoshimi, T., Yoshihara, I., Inagami, T., Ueda, S., Kato, J., Kitamura, K., Eto, T., & Kangawa, K. (1991). Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes. American Journal of Hypertension, 4(11), 909-912. https://doi.org/10.1093/ajh/4.11.909
Nakazaki, A., Hashimoto, K., Ikeda, A., Shibata, T., & Nishikawa, T. (2017). De novo synthesis of possible candidates for the Inagami–Tamura endogenous digitalis-like factor. The Journal of Organic Chemistry, 82(17), 9097-9111. https://doi.org/10.1021/acs.joc.7b01640
Nikitina, E. R., Mikhailov, A. V., Nikandrova, E. S., Frolova, E. V., Fadeev, A. V., Shman, V. V., Shilova, V. Y., Tapilskaya, N. I., Shapiro, J. I., Lakatta, E. G., & Bagrov, A. Y. (2011). In preeclampsia endogenous cardiotonic steroids induce vascular fibrosis and impair relaxation of umbilical arteries. Journal of Hypertension, 29(4), 769-776. https://doi.org/10.1097/hjh.0b013e32834436a7
Packer, M., Holcomb, R., Abraham, W. T., Anker, S., Dickstein, K., Filippatos, G., Krum, H., Maggioni, A. P., McMurray, J. J., Mebazaa, A., O'Connor, C., Peacock, W. F., Ponikowski, P., Ruschitzka, F., van Veldhuisen, D. J., Holzmeister, J., & Gimpelewicz, C. (2016). Rationale for and design of the TRUE‐AHF trial: The effects of ularitide on the short‐term clinical course and long‐term mortality of patients with acute heart failure. European Journal of Heart Failure, 19(5), 673-681. https://doi.org/10.1002/ejhf.698
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Pascale, A., & Govoni, S. (2020). Brain-heart communication: Hardware and software strategies through nerves and humoral factors. In Brain and heart dynamics (pp. 1-17). Springer. http://dx.doi.org/10.1007/978-3-319-90305-7_4-1
Păun, N., Nicolae, C., Grigore, M., Iliesiu, A. M., Coman, A., Fulga, I., & Apetroaei, M. (2025). Natriuretic peptides - A valuable target in the treatment of heart failure. Farmacia Journal, 73(1), 19-32. http://dx.doi.org/10.31925/farmacia.2025.1.3
Pawłowicz-Szlarska, E., Vanholder, R., Sever, M. S., Tuğlular, S., Luyckx, V., Eckardt, K. U., Ivanov, D., Nistor, I., Slama, S., Lameire, N., & Renal Disaster Relief Task Force of the European Renal Association. (2023). Distribution, preparedness and management of Ukrainian adult refugees on dialysis—an international survey by the Renal Disaster Relief Task Force of the European Renal Association. Nephrology Dialysis Transplantation, 38(10), 2407-2415. https://doi.org/10.1093/ndt/gfad073
Perrone, L., & Valente, M. (2021). The emerging role of metabolism in brain-heart axis: New challenge for the therapy and prevention of Alzheimer disease. May thioredoxin interacting protein be a new therapeutic target? Biomolecules, 11(11), 1652. https://doi.org/10.3390/biom11111652
Piao, Y. R., Liu, Y., Chu, C. P., Li, Y. Z., & Qiu, D. L. (2025). Activation of atrial natriuretic peptide receptor A depresses hypothalamic PVN CRFergic neuronal excitability by inhibiting IH in vitro in mice. Neuroscience Letters, 853, 138202. https://doi.org/10.1016/j.neulet.2025.138202
Popovych, I. L., Kul'chyns'kyi, A. B., Korolyshyn, T. A., & Zukow, W. (2017). Interrelations between changes in parameters of HRV, EEG and cellular immunity at patients with chronic pyelonephrite and cholecystite. Journal of Education, Health and Sport, 7(10), 11-23. https://apcz.umk.pl/JEHS/article/view/4913
Popovych, I., Mysula, I., Popovych, A., Mysula, Y., Sydliaruk, N., Bilas, V., & Zukow, W. (2021). Role of organic carbon and nitrogen of mineral waters in their immunomodulating effects at female rats. Journal of Education, Health and Sport, 11(9), 886–894. https://doi.org/10.12775/JEHS.2021.11.09.104
Portaluppi, F., Tiseo, R., Smolensky, M. H., Hermida, R. C., Ayala, D. E., & Fabbian, F. (2012). Circadian rhythms and cardiovascular health. Sleep Medicine Reviews, 16(2), 151-166. https://doi.org/10.1016/j.smrv.2011.04.003
Potter, L. R., Abbey-Hosch, S., & Dickey, D. M. (2006). Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine Reviews, 27(1), 47-72. https://doi.org/10.1210/er.2005-0014
Potter, L. R., Yoder, A. R., Flora, D. R., Antos, L. K., & Dickey, D. M. (2009). Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applications. Handbook of Experimental Pharmacology, 191, 341-366. https://doi.org/10.1007/978-3-540-68964-5_15
Ren, J., Gao, X., Guo, X., Wang, N., & Wang, X. (2022). Research progress in pharmacological activities and applications of cardiotonic steroids. Frontiers in Pharmacology, 13, 902459. https://doi.org/10.3389/fphar.2022.902459
Richards, A. M., Nicholls, M. G., Espiner, E. A., Ikram, H., Cullens, M., & Hinton, D. (1988). Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clinical and Experimental Hypertension, 10(2), 267-277. https://doi.org/10.3109/10641968609074769
Rossi, G., Manunta, P., Hamlyn, J. M., Pavan, E., De Toni, R., Semplicini, A., & Pessina, A. C. (1995). Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: Relationship with plasma renin, aldosterone and blood pressure. Journal of Hypertension, 13(10), 1181-1191. https://doi.org/10.1097/00004872-199510000-00013
Ruginsk, S. G., Elias, L. L. K., Antunes-Rodrigues, J., & Mecawi, A. S. (2023). Neuroendocrine regulation of hydrosaline metabolism. In M. Caprio & F. L. Fernandes-Rosa (Eds.), Hydro saline metabolism. Endocrinology. Springer. https://doi.org/10.1007/978-3-031-27119-9_1
Sarzani, R., Allevi, M., Di Pentima, C., Schiavi, P., Giulietti, F., Leoncini, G., Spannella, F., & Borghi, C. (2022). Role of cardiac natriuretic peptides in heart structure and function. International Journal of Molecular Sciences, 23(22), 14415. https://doi.org/10.3390/ijms232214415
Schoner, W., & Scheiner-Bobis, G. (2007). Endogenous and exogenous cardiac glycosides and their mechanisms of action. American Journal of Cardiovascular Drugs, 7(3), 173-189. https://doi.org/10.2165/00129784-200707030-00004
Schoner, W., & Scheiner-Bobis, G. (2008). Role of endogenous cardiotonic steroids in sodium homeostasis. Nephrology Dialysis Transplantation, 23(9), 2723-2729. https://doi.org/10.1093/ndt/gfn325
Seredynska, N. M., Filipets, N. D., Filipets, O. O., Slobodian, K. V., & Hozhenko, A. I. (2019). Experimental models of kidney diseases to study pathogenetic mechanisms and efficacy of pharmacological correction against the background of comorbid pathology. Zaporozhskyi Medytsynskyi Zhurnal, 21(3), 386-390. http://dx.doi.org/10.14739/2310-1210.2019.3.169197
Sever, L., Pehlivan, G., Canpolat, N., Saygılı, S., Ağbaş, A., Demirgan, E., Oh, J., Ivanov, D., Luyckx, V., Vanholder, R., & Sever, M. S. (2023). Management of pediatric dialysis and kidney transplant patients after natural or man-made disasters. Pediatric Nephrology, 38(2), 315-325. https://doi.org/10.1007/s00467-022-05734-8
Sever, M. S., Vanholder, R., Luyckx, V., Eckardt, K. U., Kolesnyk, M., Wiecek, A., Ivanov, D., Nistor, I., De Sutter, J., Covic, A., Tuglular, S., Slama, S., Lameire, N., & Renal Disaster Relief Task Force of the ERA. (2023). Armed conflicts and kidney patients: a consensus statement from the Renal Disaster Relief Task Force of the ERA. Nephrology Dialysis Transplantation, 38(1), 56-65. https://doi.org/10.1093/ndt/gfac247
Shi, L., Wang, Y. F., Zhang, G. F., Li, Y., Yao, M. L., Li, J. C., Zhao, J. Z., & Wang, E. N. (2025). Cerebral salt wasting syndrome as a probable cause of postoperative polyuria in patients with supratentorial non-midline tumors: A prospective observational study. Neurosurgical Review. https://doi.org/10.1007/s10143-025-03425-0
Shoji, M., Kimura, T., Matsui, K., Oikawa, K., Iitake, K., Inoue, M., Abe, K., & Yoshinaga, K. (1987). Effects of centrally administered atrial natriuretic peptide on renal functions. Acta Endocrinologica, 115(4), 433-440. https://doi.org/10.1530/acta.0.1150433
Steinhelper, M. E. (1993). Structure, expression, and genomic mapping of the mouse natriuretic peptide type-B gene. Circulation Research, 72(5), 984-992. https://doi.org/10.1161/01.res.72.5.984
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H. Y., Corbett, M. S., Eldridge, S. M., Emberson, J. R., Hernán, M. A., Hopewell, S., Hróbjartsson, A., Junqueira, D. R., Jüni, P., Kirkham, J. J., Lasserson, T., Li, T., ... Higgins, J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898. https://doi.org/10.1136/bmj.l4898
Sudoh, T., Kangawa, K., Minamino, N., & Matsuo, H. (1988). A new natriuretic peptide in porcine brain. Nature, 332(6159), 78-81. https://doi.org/10.1038/332078a0
Sudoh, T., Minamino, N., Kangawa, K., & Matsuo, H. (1990). C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain. Biochemical and Biophysical Research Communications, 168(2), 863-870. https://doi.org/10.1016/0006-291X(90)92401-K
Tamura, S., Okada, M., Kato, S., Shinoda, Y., Shioda, N., Fukunaga, K., Yamamoto, Y., & Ueda, M. (2018). Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect. Scientific Reports, 8(1), 2305. https://doi.org/10.1038/s41598-018-20663-z
Tuğlular, S., Luyckx, V., Vanholder, R., Skoberne, A., Wiecek, A., Nistor, I., Eckardt, K. U., Ivanov, D., Slama, S., Lameire, N., Sever, M. S., & Renal Disaster Relief Task Force of the ERA. (2023). Lessons learned during the war in Ukraine: a report from the Renal Disaster Relief Task Force of the ERA. Nephrology Dialysis Transplantation, 38(9), 1960-1968. https://doi.org/10.1093/ndt/gfad053
Tverskoi, A. M., Poluektov, Y. M., Klimanova, E. A., Mitkevich, V. A., Makarov, A. A., & Lopina, O. D. (2021). Depth of the steroid core location determines the mode of Na, K-ATPase inhibition by cardiotonic steroids. International Journal of Molecular Sciences, 22(24), 13268. https://doi.org/10.3390/ijms222413268
van Stralen, K. J., Krischock, L., Schaefer, F., Verrina, E., Groothoff, J. W., Evans, J., Hamilton, A. J., Warady, B. A., Alexander, S. R., Geary, D., Paglialonga, F., Edefonti, A., Zurowska, A., Jankauskiene, A., Bjerre, A., Roussinov, D., Stefanidis, C. J., Printza, N., Rees, L., ... Jager, K. J. (2012). Prevalence and predictors of the sub-target Hb level in children on dialysis. Nephrology Dialysis Transplantation, 27(10), 3950-3957. https://doi.org/10.1093/ndt/gfs178
Vanholder, R., De Weggheleire, A., Ivanov, D. D., Luyckx, V., Slama, S., Lameire, N., & Sever, M. S. (2022). Continuing kidney care in conflicts. Nature Reviews Nephrology, 18(8), 479-480. https://doi.org/10.1038/s41581-022-00588-7
Vesely, D. L. (2013a). Atrial natriuretic peptide prohormone gene expression: Hormones and diseases that upregulate its expression. IUBMB Life, 53(3), 153-159. https://doi.org/10.1080/15216540212336
Vesely, D. L. (2013b). Natriuretic peptides and acute renal failure. American Journal of Physiology-Renal Physiology, 285(2), F167-F177. https://doi.org/10.1152/ajprenal.00259.2002
Vidal, E., van Stralen, K. J., Chesnaye, N. C., Bonthuis, M., Holmberg, C., Bjerre, A., Palsson, R., Harambat, J., Groothoff, J. W., Caliskan, S., Stefanidis, C. J., Ariceta, G., Battelino, N., Heaf, J., Ivanov, D., Topaloglu, R., Roussinov, D., Bakkaloglu, S., Vondrak, K., ... Jager, K. J. (2017). Infants requiring maintenance dialysis: outcomes of hemodialysis and peritoneal dialysis. American Journal of Kidney Diseases, 69(5), 617-625. https://doi.org/10.1053/j.ajkd.2016.09.024
Vinnakota, S., & Chen, H. H. (2020). The importance of natriuretic peptides in cardiometabolic diseases. Journal of the Endocrine Society, 4(6), bvaa052. https://doi.org/10.1210/jendso/bvaa052
Volpe, M., Carnovali, M., & Mastromarino, V. (2016). The natriuretic peptides system in the pathophysiology of heart failure: From molecular basis to treatment. Clinical Science, 130(2), 57-77. https://doi.org/10.1042/cs20150469
Voronenko, Y. V., Mintser, O. P., & Ivanov, D. D. (2012). Современная философия трансфера знаний в последипломном медицинском образовании [Modern philosophy of knowledge transfer in postgraduate medical education]. Pochki, 15-16.
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W., & Vasan, R. S. (2004). Impact of obesity on plasma natriuretic peptide levels. Circulation, 109(5), 594-600. https://doi.org/10.1161/01.cir.0000112582.16683.ea
Weigand, K. M., Laursen, M., Swarts, H. G., Engwerda, A. H., Prüfert, C., Sandrock, J., Koster, A. S., Blankesteijn, W. M., Russel, F. G., & Koenderink, J. B. (2014). Na+,K+-ATPase isoform selectivity for digitalis-like compounds is determined by two amino acids in the first extracellular loop. Chemical Research in Toxicology, 27(12), 2082-2092. https://doi.org/10.1021/tx500290k
Wells, G. A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Yasoda, A. (2022). Physiological and pathophysiological effects of C-type natriuretic peptide on the heart. Biology, 11(6), 911. https://doi.org/10.3390/biology11060911
Yeung, V. T., Ho, S. K., Leung, D. N., Stadlin, A., Nicholls, M. G., & Cockram, C. S. (1993). Binding of atrial and brain natriuretic peptides to cultured mouse astrocytes from different brain regions and effect on cyclic GMP production. Glia, 9(4), 243-247. https://doi.org/10.1002/glia.440090402
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Anatoliy Gozhenko, Walery Zukow, Dmytro Ivanov, Natalia Filipets, Olena Gozhenko
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 302
Number of citations: 0
